Ellutia Presents Failsafe Total Nitrosamine Testing in Pharmaceuticals at Pittcon 2020
Ellutia Chromatography Solutions Ltd, Booth 2326, Pittcon 2020, March 1-5, Chicago
drug safety
Edible 'Security Tag' to Protect Drugs from Counterfeiting
To imitate the drug, a counterfeiter would have to uncrack a complicated puzzle of patterns not fully visible to the naked eye
Bio-Rad Launches iQ-Check Aspergillus Real-Time PCR Kit, a Fast PCR Alternative for Detection of Aspergillus in Cannabis and Cannabis-Infused Products
Depending on the jurisdiction, companies selling cannabis-derived products may need to comply with pathogen testing to protect consumers from harmful microorganisms, including Aspergillus spp.
Novel Mathematical Framework Provides a Deeper Understanding of How Drugs Interact
eEucidating how two given drugs interact, and whether they have a beneficial effect, would mean a major step toward drug development to treat diseases more effectively in the future
FDA Releases an Additional LC-MS Method for Testing NDMA in Ranitidine (Zantac)
New LC-MS/MS method provides an alternative to the current LC-HRMS method
NDMA Testing Methods
Ranitidine (Zantac) recall brings into question the analytical methods used to detect NDMA
Health Risks Associated with N-Nitrosodimethylamine (NDMA)
Detection of NDMA in ranitidine drugs (Zantac) led to a recent recall. While the carcinogenic effects in humans are not conclusive, NDMA is considered a probable human carcinogen
Ranitidine (Zantac) Recall Brings into Question Accuracy of Safety Testing Methods
Company that detected impurities in ranitidine drugs says FDA testing methodology is insufficient, while FDA counters that the company’s testing method was inaccurate
Flipping the View: New Microscope Offers Options for Drug Discovery, Safety
A Purdue University team developed the microscope based on concepts of phase-contrast microscopy
Certara Demonstrates Proof of Concept for its Virtual Twin™ Technology
In two papers, Virtual Twin employs modeling and simulation to determine the optimal drug dosing regimen and assess cardiac toxicity risk for individual patients